Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-04-01
2000-05-02
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514323, 546199, 546201, A61K 31445, C07D40100
Patent
active
060573384
ABSTRACT:
This invention relates to somatostatin agonist compounds which are potent with high selectivity toward the receptor subtype 2. Compounds of the formula: ##STR1## including pharmaceutically acceptable salts and hydrates thereof are disclosed. These compounds are useful in the treatment of diabetes, cancer, acromegaly, restenosis, depression, irritable bowel syndrome, pain and diabetic retinopathy. Many of the compounds are also orally active.
REFERENCES:
patent: 4242347 (1980-12-01), Huebner
patent: 4310518 (1982-01-01), Freidinger et al.
patent: 5360807 (1994-11-01), Janssens et al.
patent: 5710155 (1998-01-01), Schnorrenberg et al.
patent: 5869489 (1999-02-01), Shah et al.
Chem. Abs., vol. 119, No. 23, p. 69, col. 1, 1993.
Chem. Abs., vol. 128, No. 2, p. 386, col. 1, 1998.
Chem. Abs., vol. 128, No. 19, p. 604, col. 2, 1998.
Betoin et al. "In vitro and in vivo evidence for a tachykinin NK1 receptor antagonist effect of vapreotide, an analgesic cyclic analog of somatostatin" CA 123:26282, 1995.
Berk Scott
Pasternak Alexander
Patchett Arthur A.
Yang Lihu
Chang Ceila
McGinnis James L.
Merck & Co. , Inc.
Rose David L.
LandOfFree
Somatostatin agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Somatostatin agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Somatostatin agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1594137